Phnom Penh (FN), Aug. 4 – On 3 August in Phnom Penh the leading companies of The Royal Group of Companies (Cambodia), Fresh Start (Australia) and Aegros (Australia) announced a partnership for the collection of Plasma throughout ASEAN and its fractionation into life saving products.
The world, especially Asia, has a shortage of Plasma products which is impacting the wellbeing of so many individuals across all counties. This partnership is a significant step in the progress of health development working towards a goal to give ASEAN counties more availability of Plasma treatment products.
Plasma is extracted from Blood and it has many important health uses including: a. Cancer treatments; b. Hemophilia Management; and c. many more medical treatments
Neak Oknha Kith Meng, chairman and CEO of Royal Group said that "the Joint Venture company will be called Royal Group Plasma Fractionation and will: a. collect Plasma across Asia; b. build a new plasma fractionation facility in Singapore at USD400 million to fractionate 1 million litres per year of the Asian plasma; and c. build a Fill & Finish facility in Cambodia to bottle, package and distribute plasma products".
Daniel Phillips, CEO of Fresh Start Australia Pty Ltd said that "the new Plazma framenation technology, created by Aegros Limited and called HaemaFracR will make Plasma products to: a produce urgently needed live saving plasma products to supply a grossly undersupplied ASEAN market and at an affordable cost; b. create new jobs in both Singapore and Cambodia; c. contribute to new export income/taxes for Singapore, Cambodia, and Australia; and d. place Singapore and Cambodia on the regional health leadership stage”.
Aegros Limited is a market innovator in health that saves and improves people's lives. It has changed an old industry that had not changed for over 70 years. Aegros will now bring its Australian technology across the World including Asia.
Co-Founder of Aegros Professor Hari Nair said today, "Our technology and IP will not just change the way Australia undertakes plasma fractionation but how plasma is fractionated globally. This deal represents Aegros' first overseas expansion and in another world first, will use plasma currently collected in Asia which cannot be processed by the existing fractionators."
"The Asian market represents approximately 60% of the world's population but only represents approximately 30% of the therapeutic plasma product sales. It is a grossly undersupplied market," John Manusu, co-founder said today.
About The Royal Group
The Royal Group is Cambodia's strategic investment holding company, recognised as the country's most dynamic and diversified business conglomerate. With interests in a wide range of industries including telecommunication, transport, energy, media & entertainment, banking & financing, insurance, hotels & resorts, education, property development, trading and agriculture.
The company is a strategic investment gateway to Cambodia with a history of successful, market-leading partnerships with investors in a diverse range of industries, and offers overwhelming investment potential in one of the first truly free-market economies in the Mekong Region of Asia.
For more information about Royal Group, please visit - www.royalgroup.com.kh or contact media@royalgroup.com.kh
About Aegros Limited
Aegros is the Australian plasma fractionator who have developed a novel Plasma fractionation process called the HaemaFrac®.
For more information about Aegros Limited, please visit www.aegros.com.au
About Fresh Start Australia Pty Ltd
Fresh Start is an established entity undertaking a broad area of investments and activities in Australia and other global locations.
For more information about Fresh Start Australia Pty Ltd, please visit — www.freshstartaustralia.com.au
Contact for media inquiries:
For more information
contact-Dr Raymon Kirwan on raymond.kirwan@royalgroup.com.kh or call +855 (0) 77 555 258
=FRESH NEWS
